These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10913806)

  • 21. Sizing clinical trials when comparing bivariate time-to-event outcomes.
    Sugimoto T; Hamasaki T; Evans SR; Sozu T
    Stat Med; 2017 Apr; 36(9):1363-1382. PubMed ID: 28120524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative analyses for antiepileptic drug trials.
    Pledger GW; Sahlroot JT
    Epilepsy Res Suppl; 1993; 10():167-74. PubMed ID: 8251092
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 24. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rank-based sample size method for multiple outcomes in clinical trials.
    Huang P; Woolson RF; O'Brien PC
    Stat Med; 2008 Jul; 27(16):3084-104. PubMed ID: 18189338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size determination in complex clinical trials comparing more than two groups for survival endpoints.
    Ahnn S; Anderson SJ
    Stat Med; 1998 Nov; 17(21):2525-34. PubMed ID: 9819843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sample size calculation for the van Elteren test adjusting for ties.
    Zhao YD; Rahardja D; Mei Y
    J Biopharm Stat; 2008; 18(6):1112-9. PubMed ID: 18991111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the variability of covariate adjustment. experience with Koch's method for evaluating the absolute difference in proportions in randomized clinical trials.
    Lesaffre E; Bogaerts K; Li X; Bluhmki E
    Control Clin Trials; 2002 Apr; 23(2):127-42. PubMed ID: 11943440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some Issues of Sample Size Calculation for Time-to-Event Endpoints Using the Freedman and Schoenfeld Formulas.
    Abel UR; Jensen K; Karapanagiotou-Schenkel I; Kieser M
    J Biopharm Stat; 2015; 25(6):1285-311. PubMed ID: 25629760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring mortality at interim analyses while testing a composite endpoint at the final analysis.
    Chen YH; DeMets DL; Lan KK
    Control Clin Trials; 2003 Feb; 24(1):16-27. PubMed ID: 12559639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early stopping of prevention trials when multiple outcomes are of interest: a discussion.
    Green SB; Freedman LS
    Stat Med; 1994 Jul 15-30; 13(13-14):1479-84. PubMed ID: 7973227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel sample size formula for the weighted log-rank test under the proportional hazards cure model.
    Xiong X; Wu J
    Pharm Stat; 2017 Jan; 16(1):87-94. PubMed ID: 27860138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
    Beisel C; Benner A; Kunz C; Kopp-Schneider A
    Biom J; 2017 May; 59(3):511-530. PubMed ID: 28263395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A simple method for calculating power based on a prior trial.
    Borm GF; Bloem BR; Munneke M; Teerenstra S
    J Clin Epidemiol; 2010 Sep; 63(9):992-7. PubMed ID: 20573484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rank tests for clustered survival data.
    Jung SH; Jeong JH
    Lifetime Data Anal; 2003 Mar; 9(1):21-33. PubMed ID: 12602772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some practical aspects of the interim monitoring of clinical trials.
    Simon R
    Stat Med; 1994 Jul 15-30; 13(13-14):1401-9. PubMed ID: 7973219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials.
    Zhang Z; Chen R; Soon G; Zhang H
    Stat Med; 2018 Jan; 37(1):1-11. PubMed ID: 28948633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.